featured
Safety and Efficacy of Continuous Subcutaneous Levodopa–Carbidopa Infusion for Parkinson's Disease With Motor Fluctuations
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The Lancet Neurology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Safety and efficacy of continuous subcutaneous levodopa-carbidopa infusion (ND0612) for Parkinson's disease with motor fluctuations (BouNDless): a phase 3, randomised, double-blind, double-dummy, multicentre trial
Lancet Neurol 2024 Mar 15;[EPub Ahead of Print], AJ Espay, F Stocchi, R Pahwa, A Albanese, A Ellenbogen, JJ Ferreira, N Giladi, T Gurevich, S Hassin-Baer, J Hernandez-Vara, SH Isaacson, K Kieburtz, PA LeWitt, L Lopez-Manzanares, CW Olanow, W Poewe, H Sarva, T Yardeni, L Adar, L Salin, N Lopes, N Sasson, R Case, O RascolFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.